Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
296 studies found for:    leukemia AND (women OR woman OR female)
Show Display Options
Download search resultsDownload the search results for:
leukemia AND (women OR woman OR female) (296 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Genetic: gene expression analysis;   Other: flow cytometry;   Other: fluorescence activated cell sorting;   Other: laboratory biomarker analysis;   Other: medical chart review
2 Recruiting Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy
Conditions: Acute Promyelocytic Leukemia;   Pregnancy
Intervention:
3 Not yet recruiting Correlation Between LIF (Leukemia Inhibitory Factor ) Levels in Cord and Maternal Blood in Women Treated With Mg
Condition: LIF LEVELS IN CORD BLOOD AND MATERNAL BLOOD DURING LABOR
Intervention: Other: blood sample and tissue sample
4 Active, not recruiting Eltrombopag in Elderly Acute Myelogenous Leukemia (AML)
Condition: Male and Female Subjects, Greater Than 60 Years of Age With Non-M3 AML
Intervention: Drug: Eltrombopag
5 Completed A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure
Condition: Infertility, Implantation Failure.
Intervention: Drug: Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)
6 Completed r-hLIF for Improving Embryo Implantation in IVF
Condition: Infertility, Implantation Failure.
Intervention: Drug: Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)
7 Completed An Extension Study of the Safety and Anti-leukemic Effects of Imatinib Mesylate in Patients (Male or Female ≥18 Years) With Ph + CML in Blast Crisis
Condition: Philadelphia Positive Chronic Myeloid Leukemia in Myeloid Blast Crisis
Intervention: Drug: imatinib mesylate
8 Recruiting Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Gastrointestinal Stromal Tumor;   Premenopausal
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Procedure: Ultrasonography
9 Terminated Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Cardiac Toxicity;   Inflammatory Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: cyclophosphamide;   Drug: paclitaxel;   Biological: trastuzumab;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Drug: tamoxifen citrate;   Other: laboratory biomarker analysis
10 Terminated
Has Results
Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Panobinostat - LBH589
11 Recruiting B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging
Condition: Chronic Lymphocytic Leukemia
Intervention:
12 Not yet recruiting National Observatory of Chronic Myeloid Leukemia Adolescent and Young Adults Treated With Tyrosine Kinase Inhibitors in First Intent
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
13 Completed Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation
Condition: Chronic Lymphocytic Leukemia
Intervention: Procedure: Leukemia cell harvest
14 Recruiting B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression
Condition: Chronic Lymphocytic Leukemia
Intervention:
15 Terminated
Has Results
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome
Intervention: Drug: deferoxamine
16 Recruiting A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Conditions: CLL (Chronic Lymphocytic Leukemia);   SLL (Small Lymphocytic Lymphoma)
Interventions: Drug: Ibrutinib;   Drug: Fludarabine
17 Completed Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
Conditions: Acute Myelogenous Leukemia;   Myelodysplasia
Intervention: Biological: autologous tumor cells
18 Recruiting Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia
Conditions: Recurrent Adult Acute Myeloid Leukemia;   Acute Myeloid Leukemia, in Relapse
Intervention: Drug: MEN1112
19 Completed Phase IV Observational Study in Chronic Lymphocytic Leukemia
Condition: Leukaemia, Lymphocytic, Chronic
Intervention: Drug: Arzerra
20 Not yet recruiting Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates
Condition: to Compare LIF Level in Cord Blood of Embryo's That Are IUGR to Those That Are AGA
Intervention: Other: blood sample and tissue sample

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.